dsip delta sleep inducing peptide human studies DSIP | Peak Biosciences
Description
Current Treatment Methods for PSC Currently available treatment methods for Primary Sclerosing Cholangitis remain limited, with no approved therapies specifically targeting the underlying disease mechanism
10.1016/j.jgg.2021.11.005 21 JiangY.ZhaoL.ChenQ.ZhouL
doi: 10.1615/critrevimmunol.v32.i6.10 74 MengXMTangPMLiJLanHY
This review provides an outlook on emerging targets for future therapies of Parkinson disease
